Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
WuXi Biologics Initiated Construction of a State-of-the-Art Integrated ADC Solution Center 2018-06-20 08:03
WuXi Biologics to Invest $60 Million to Establish a Biologics Production Facility in the United States 2018-06-11 08:34
WuXi Biologics and Tsinghua University Innovation Center for Immune Therapy Sign MOU and Announce Strategic Partnership 2018-05-30 08:34
WuXi Biologics to Invest S$80 Million to Establish a Biologics Manufacturing Facility in Singapore 2018-05-22 18:34
WuXi Biologics and Bioasis Announce Initial Strategic Collaboration for the Development and Manufacturing of Bioasis' Lead Investigational Candidate to Treat Brain Cancer 2018-05-21 20:30
WuXi Biologics to Build an Integrated Biologics Development, Clinical and Commercial Manufacturing Center in Shijiazhuang 2018-05-16 18:09
WuXi Biologics to Invest €325 Million to Build Largest Biomanufacturing Facility Using Single-Use Bioreactors in Ireland 2018-04-30 20:41
WuXi Biologics Wins CMO Leadership Award from Life Science Leader Magazine 2018-04-17 08:13
WuXi Biologics to Install Industry's Largest Single-Use Bioreactor from ABEC at its New Commercial Manufacturing Facility 2018-03-21 08:18
WuXi Biologics Reports Remarkable 2017 Annual Results: Revenue up 63.7% to a Record High of RMB1,618.8 Million 2018-03-19 20:41
WuXi Biologics and Adagene Announce Strategic Development and Manufacturing Partnership 2018-03-09 11:43
WuXi Biologics Receives Asia's CMO of 2017 from BioPharma Industry Awards 2018-03-06 14:11
WuXi Biologics Announces Positive Profit Alert 2018-03-05 17:48
WuXi Biologics Congratulates MabSpace on FDA Clearance of IND for MSB2311 2018-02-27 08:04
WuXi Biologics Congratulates Tychan for Dosing First Patient of a Zika Antibody after Record 9 Months of Development 2018-02-09 09:04
WuXi Biologics Congratulates BioAtla on FDA Clearance of IND Application for CAB-AXL-ADC 2018-01-31 07:52
WuXi Biologics and Aravive Biologics to Form Strategic Manufacturing Collaboration Following Successful IND Filing for AVB-S6-500 2018-01-30 09:00
WuXi Biologics Announces Formation of Scientific Advisory Board 2018-01-24 17:05
WuXi Biologics Appoints Dr. Chiang Syin, a Former FDA Officer as Chief Quality Officer 2018-01-15 08:10
WuXi Biologics and Phanes Sign MOU and Announce Strategic Development and Manufacturing Partnership 2017-12-14 17:20
1 5 6 7 8 9